Aligos Therapeutics Inc
NASDAQ:ALGS
Aligos Therapeutics Inc
NASDAQ:ALGS
Price:
4.96
USD
1.02%
Market Closed
Market Cap:
$30.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
SSAB AB
F:SKWA
|
SE |
|
Patterson Companies Inc
NASDAQ:PDCO
|
US |
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
R
|
Revvity Inc
NYSE:RVTY
|
US |
|
Adecoagro SA
NYSE:AGRO
|
LU |
|
D
|
Douyu International Holdings Ltd
SWB:DY8A
|
CN |
|
Air China Ltd
SSE:601111
|
CN |
|
M
|
Mercedes Benz Group AG
DUS:MBG
|
DE |
|
Grifols SA
MAD:GRF
|
ES |
|
A
|
Adtalem Global Education Inc
XBER:DVY
|
US |
|
Canada Goose Holdings Inc
TSX:GOOS
|
CA |
|
Camber Energy Inc
OTC:CEIN
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
L
|
Link Real Estate Investment Trust
OTC:LKREF
|
HK |
|
E
|
Exotic Food PCL
SET:XO
|
TH |
|
Tata Motors Passenger Vehicles Ltd
NSE:TMPV
|
IN |
Multiples-Based Value
The Multiples-Based Value for Aligos Therapeutics Inc (ALGS) under the Base Case is hidden
USD.
Compared with the current market price of 4.96 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALGS Multiples-Based Value
LOCKED
